# Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding

> **NCT01448616** · PHASE4 · COMPLETED · sponsor: **University of Washington** · enrollment: 73 (actual)

## Conditions studied

- Herpes Simplex Type II

## Interventions

- **DRUG:** TDF
- **DRUG:** Placebo Vaginal Gel
- **DRUG:** Vaginal TFV Gel
- **DRUG:** Placebo Tablets

## Key facts

- **NCT ID:** NCT01448616
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2023-02-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01448616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01448616, "Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01448616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*